Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intrauterine flushing with human chorionic gonadotropin to improve ICSI outcomes in women with infertility; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human chorionic gonadotropin (human chorionic gonadotropin)

Snippet

Sponsor: Omayma Ismail Khalaf | Conditions: Female Infertility | Phase 4 | Status: COMPLETED | Results posted: 2025-04-27